These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

175 related items for PubMed ID: 2672418

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Histochemistry of MPTP oxidation in the rat brain: sites of synthesis of the parkinsonism-inducing toxin MPP+.
    Nakamura S, Vincent SR.
    Neurosci Lett; 1986 Apr 24; 65(3):321-5. PubMed ID: 3487052
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Role for monoamine oxidase-A (MAO-A) in the bioactivation and nigrostriatal dopaminergic neurotoxicity of the MPTP analog, 2'Me-MPTP.
    Kindt MV, Youngster SK, Sonsalla PK, Duvoisin RC, Heikkila RE.
    Eur J Pharmacol; 1988 Feb 09; 146(2-3):313-8. PubMed ID: 3131149
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Inhibition of NADH-linked oxidation in brain mitochondria by 1-methyl-4-phenyl-pyridine, a metabolite of the neurotoxin, 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine.
    Nicklas WJ, Vyas I, Heikkila RE.
    Life Sci; 1985 Jul 01; 36(26):2503-8. PubMed ID: 2861548
    [Abstract] [Full Text] [Related]

  • 9. Bioactivation of MPTP: reactive metabolites and possible biochemical sequelae.
    Trevor AJ, Castagnoli N, Caldera P, Ramsay RR, Singer TP.
    Life Sci; 1987 Feb 23; 40(8):713-9. PubMed ID: 3492651
    [Abstract] [Full Text] [Related]

  • 10. Parkinsonism-inducing neurotoxin, N-methyl-4-phenyl-1,2,3,6 -tetrahydropyridine: uptake of the metabolite N-methyl-4-phenylpyridine by dopamine neurons explains selective toxicity.
    Javitch JA, D'Amato RJ, Strittmatter SM, Snyder SH.
    Proc Natl Acad Sci U S A; 1985 Apr 23; 82(7):2173-7. PubMed ID: 3872460
    [Abstract] [Full Text] [Related]

  • 11. Commentary on "Biochemical mechanism of action of the dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)'.
    Di Monte D, Wu EY, Smith MT.
    Toxicol Lett; 1989 Aug 23; 48(2):117-9. PubMed ID: 2788940
    [No Abstract] [Full Text] [Related]

  • 12. Metabolism of the neurotoxin in MPTP by human liver monoamine oxidase B.
    Fritz RR, Abell CW, Patel NT, Gessner W, Brossi A.
    FEBS Lett; 1985 Jul 08; 186(2):224-8. PubMed ID: 3874094
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The actions of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in animals as a model of Parkinson's disease.
    Jenner P, Marsden CD.
    J Neural Transm Suppl; 1986 Jul 08; 20():11-39. PubMed ID: 3091760
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The interaction of 1-alkyl-4,4-diphenylpiperidines with the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine receptor binding site.
    Russ H, Pindur U, Przuntek H.
    J Neural Transm; 1986 Jul 08; 65(3-4):157-66. PubMed ID: 3011983
    [Abstract] [Full Text] [Related]

  • 18. Potential bioactivation pathways for the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).
    Castagnoli N, Chiba K, Trevor AJ.
    Life Sci; 1985 Jan 21; 36(3):225-30. PubMed ID: 3871243
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Dopaminergic toxicity of rotenone and the 1-methyl-4-phenylpyridinium ion after their stereotaxic administration to rats: implication for the mechanism of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine toxicity.
    Heikkila RE, Nicklas WJ, Vyas I, Duvoisin RC.
    Neurosci Lett; 1985 Dec 18; 62(3):389-94. PubMed ID: 3912685
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.